The Board of the EuroQol Research Foundation regularly reviews the EQ-5D user license policy. Recently, a decision has been made to extend free use to all non-commercial users. Therefore, as of today, 18 January 2019, the EuroQol Research Foundation will…
The EuroQol Office published a new version of the EQ-5D-3L User Guide, which is is now available for download at the EuroQol website: A change to the EQ-5D-3L, reflected in this User Guide update, has been made to the paper self-complete…
The following is an update on the current situation regarding the EQ-5D-5L value set for England. The EQ-5D-5L value set for England was published in 2018. Since then, in line with UK government quality assurance requirements, a first independent validation…
The EQ-5D has been used in clinical trials, population studies, and real world clinical settings for over 25 years and interest in using the instrument remains as strong as ever. From 1 October 2017 to 30 September 2018, 4,922 requests…
The EuroQol Office team is based in Rotterdam, the Netherlands, and supports the EuroQol Research Foundation, the EuroQol Group Association and its members. We recently produced a brief film on the EuroQol Office team, see below.
A recent literature search, supplemented with information provided by EuroQol members, revealed that EQ-5D is the recommended tool for use in cost-utility analysis by a number of Health Technology Assessment bodies around the globe (including Colombia, Czech Republic, England and…
Dr A Simon Pickard has presented the first results of the US valuation study for the EQ-5D-5L at the ISPOR Conference in Baltimore, USA on Monday 21 May 2018. The project team at the University of Illinois at Chicago used…
The journal PharmacoEconomics has recently published online a series of four articles and two commentaries on the five level version of the EQ-5D (EQ-5D-5L). One article reports the first head-to-head comparison of the descriptive systems and value sets for the…
High levels of interest in the EQ-5D-5L are demonstrated by the article by Versteegh et al (2016), who established the Dutch tariff for the EQ-5D-5L , being third in the list of most popular downloads in Value in Health 2016.…